title: Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator.
abstract: OBJECTIVE
  To assess the incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias after implantable cardioverter-defibrillator (ICD) implantation for primary prevention.
  
  
  METHODS
  Prospective observational study.
  
  
  METHODS
  41 consecutive patients, who fulfilled MADIT (multicenter automatic defibrillator implantation trial) I criteria, except for suppressibility by procainamide, and who received a prophylactic ICD.
  
  
  METHODS
  Subpectoral implantation of an ICD.
  
  
  METHODS
  Incidence of ventricular tachyarrhythmias and their electrophysiological characteristics with respect to timing of the arrhythmia, tachyarrhythmia cycle length, mode of termination, and clinical relevance.
  
  
  RESULTS
  During a mean (SD) follow up of 30 (21) months 18 of 41 (43.9%) patients experienced 142 appropriate ICD treatments. The mean (SD) time to first event was 9.6 (15.1) months. One patient had ventricular fibrillation (VF), 12 patients ventricular tachycardia (VT), and five both VT and VF. The mean (SD) cycle length of monomorphic VT was 306 (42) ms. Of 142 episodes, 117 (82.3%) were terminated by antitachycardia pacing and another 25 (17.6%) by ICD discharges. Cumulative survival of hypothetical death, defined as treated VT with a cycle length < 260 ms or VF, was 83.2% after one year and 78.4% after two years.
  
  
  CONCLUSIONS
  Patients with a left ventricular ejection fraction < 35%, a history of myocardial infarction, non-sustained VT, and inducible VT/VF are at high risk of VT/VF early after implantation. Therefore, implantation of a tiered treatment defibrillator seems to be justified.
authors.affiliation: 1st Department of Medicine-Cardiology, University Hospital of Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Mannheim, Germany. christian.wolpert@med.ma.uni-heidelberg.de
authors.forename: C
authors.initials: C
authors.lastname: Wolpert
authors.forename: J
authors.initials: J
authors.lastname: Kuschyk
authors.forename: N
authors.initials: N
authors.lastname: Aramin
authors.forename: S
authors.initials: S
authors.lastname: Spehl
authors.forename: F
authors.initials: F
authors.lastname: Streitner
authors.forename: T
authors.initials: T
authors.lastname: Süselbeck
authors.forename: B
authors.initials: B
authors.lastname: Schumacher
authors.forename: K K
authors.initials: KK
authors.lastname: Haase
authors.forename: R
authors.initials: R
authors.lastname: Schimpf
authors.forename: M
authors.initials: M
authors.lastname: Borggrefe
mesh_terms: D000368:Aged; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000379:methods*; D004594:Electrophysiology; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy; D011446:Prospective Studies; D017180:Tachycardia, Ventricular / Q000503:physiopathology* / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000503:physiopathology / Q000517:prevention & control